Abstract:Background Gout is a polygenetic inflammatory disease. Although hundreds of genetic variants associated with gout and serum urate levels have been identified in studies of adults, the pathogenesis of adolescent-onset gout remains unclear. To better characterize the genetic landscape of adolescent-onset gout, a whole genome sequencing study was done in a large Chinese adolescent-onset gout cohort. Methods We conducted whole genome sequencing in a discovery adolescent-onset gout cohort of 905 individuals (gout onset 12-19 years) to discover common SNVs, uncommon SNVs, and indels associated with gout. Candidate common SNVs were replicated in an early-onset gout cohort of 2834 individuals (gout onset ≤ 30 years old). Loci associated with early-onset gout ( P < 5.0 × 10−8) were identified after meta-analysis with the discovery and replication cohorts. Transcriptome and epigenomic analyses, RT-qPCR and RNA-seq in human peripheral blood leukocytes, and knock-down experiments in human THP-1 macrophage cells investigated regulation and functions of candidate gene RCOR1 . Findings In addition to ABCG2 , a urate transporter previously linked to pediatric-onset and early-onset gout, we identified four novel loci: VPRBP (rs868933181, P meta = 6.27 × 10−9; ORmeta = 1.66), NKILA-MIR4532 (rs72626599, P meta = 6.48 × 10−9; ORmeta = 1.58), RCOR1 (rs12887440, P meta = 3.37 × 10−8; ORmeta = 1.48), and FSTL5 - MIR4454 (rs35213808, P meta = 4.02 × 10−8; ORmeta = 1.49). Additionally, we found association at ABCG2 and SLC22A12 that was driven by low frequency SNVs. Furthermore, eight uncommon SNVs and three indels in the exome were predicted to be harmful. SNVs in RCOR1 were linked to heightened blood leukocyte mRNA levels. THP-1 macrophage culture studies revealed the potential of decreased RCOR1 to suppress gouty inflammation. Interpretation Performing the first comprehensive characterization of adolescent-onset gout genomes identified risk loci of early-onset gout. Loci mediate inflammatory responsiveness to crystals that could mediate gouty arthritis. This study will contribute to risk prediction and therapeutic interventions to prevent adolescent-onset gout. Funding The National Natural Science Foundation of China and the National Key R&D Program of China. Evidence before this study Gout is a polygenic disease and can present in adolescents and young adults. We searched PubMed for studies published as of Dec 31, 2021, without starting date or language restrictions and with the terms “adolescent-onset gout”, “early-onset gout”, “whole genome sequencing”, and “GWAS”, and no reports were found. Although GWAS have identified hundreds of genetic variants associated with gout and serum urate levels, they are all identified in adults (mean age 37.6-76.4 years old). The mechanism of early-onset gout is still unclear. The variants previously associated with early-onset gout are only in ABCG2 . Due to the lack of large-scale genetic studies of the adolescent gout population, the mechanism of the early-onset gout is unknown. Added value of this study To the best of our knowledge, this is the first report of the comprehensive characterization of adolescent gout genomes. We identified common and uncommon risk loci of early-onset gout, most of which implicated in inflammation response, including RCOR1 . SNVs in candidate risk gene RCOR1 displayed expression regulation function. Knockdown of RCOR1 decreased IL-1β levels in THP-1 cells after MSU treatment. These immune-related genetic variants leading to heightened inflammatory responses to monosodium urate (MSU) crystals may contribute to early onset of gout in adolescents. Implications of all the available evidence This is the first report of the genetic landscape of adolescent-onset gout and increases our knowledge of the biological mechanisms underlying early-onset gout. The immune-related loci associated with early-onset gout discovered in this study are potential drug targets. Reducing inflammatory MSU crystal inflammatory responses to MSU crystals is a central objective in the prevention and treatment of adolescent-onset gout. ### Competing Interest Statement The authors have declared no competing interest. ### Funding Statement The National Natural Science Foundation of China and the National Key R&D Program of China. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: This study was reviewed and approved by the ethics committee of the Affiliated Hospital of Qingdao University (QYFYKYLL923011921) and Beijing Institute of Genomics, Chinese Academy of Sciences / China National Center for Bioinformation (2015H023). I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Adolescent gout GWAS summary statistics and the genotype data can be made available on request to the corresponding author.

Analysis of causative gene mutations in one child with primary gout

Novel Genetic Loci in Early-Onset Gout Derived From Whole-Genome Sequencing of an Adolescent Gout Cohort

High-Resolution Melting Analysis for the Rapid Detection of an Intronic Single Nucleotide Polymorphism in Slc22a12 in Male Patients with Primary Gout in China

Familial juvenile hyperuricemia in early childhood in a boy with a novel gene mutation

A Pedigree Research on Mutation Sites of the Uromodulin-Encoding Gene from a Patient with Familial Juvenile Hyperuricemic Nephropathy

[A Case of Glycogen Storage Disease Type Ⅰa with Gout As the Main Clinical Manifestation].

[Genetic analysis of a child with Primary hypertrophic osteoarthropathy]

Chromosomal Localization of Primary Gout Susceptibility Gene in a Chinese Pedigree

[Genetic Diagnosis for a Chinese Han Family with Primary Hypertrophic Osteoarthropathy].

Effects of Multiple Genetic Loci on the Pathogenesis from Serum Urate to Gout

[Clinical Characteristics and Genetic Analysis of a Chinese Pedigree Affected by Glycogen Storage Disease Type Ia with Gout As the First Manifestation].

Primary hyperoxaluria type 1 in one child and literature review

Novel genetic loci in adolescent-onset gout derived from whole genome sequencing of a Chinese cohort

Single-cell and genome-wide Mendelian randomization identifies causative genes for gout

A genome-wide association analysis reveals new pathogenic pathways in gout*

Urate crystal deposition in hyperuricemic children: a dual energy computed tomography study

A Genome-Wide Association Analysis of 2,622,830 Individuals Reveals New Pathogenic Pathways in Gout

Mutational analysis of AGXT in two Chinese families with primary hyperoxaluria type 1

UMOD Gene Mutations in Chinese Patients with Autosomal Dominant Tubulointerstitial Kidney Disease: a Pediatric Case Report and Literature Review

Investigation into the association between P2RX7 gene polymorphisms and susceptibility to primary gout and hyperuricemia in a Chinese Han male population

The clinical manifestation and gene mutation of primary renal glucosuria in a child